Mark Christopher Murray - EVP, Biomaterials & AT at Avantor, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Biomaterials & AT
Stock Symbol
AVTR on NYSE
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Christopher Murray since 12/4/2023

Holdings reported by Mark Christopher Murray for Avantor, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18.7K $426K $22.83 Jan 13, 2022 Direct

Transactions reported by Mark Christopher Murray for Avantor, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.